Hypomagnesaemia and Type 2 (non-insulin-dependent) diabetes mellitus
نویسندگان
چکیده
منابع مشابه
Non-insulin-dependent diabetes mellitus.
Non-insulin-dependent diabetes mellitus (NIDDM) occurs predominantly after the age of 50 years but is not easy to distinguish from late onset insulin-dependent diabetes. It is likely that misclassification is rare in a Caucasian population. Whilst NIDDM is widely believed to be genetically determined, recent epidemiological observations have consistently revealed statistical associations betwee...
متن کاملMolecular scanning of candidate mitochondrial tRNA genes in type 2 (non-insulin dependent) diabetes mellitus.
Mitochondrial DNA (mtDNA) gene defects may play a role in the development of non-insulin dependent diabetes mellitus (NIDDM). In order to search for potentially diabetogenic mtDNA defects we have applied the technique of single stranded conformational polymorphism (SSCP) analysis to 124 patients with a history of NIDDM and 40 non-diabetic controls. No new heteroplasmic mutations were detected. ...
متن کاملInsulin management of type 2 diabetes mellitus.
Insulin therapy is recommended for patients with type 2 diabetes mellitus and an initial A1C level greater than 9 percent, or if diabetes is uncontrolled despite optimal oral glycemic therapy. Insulin therapy may be initiated as augmentation, starting at 0.3 unit per kg, or as replacement, starting at 0.6 to 1.0 unit per kg. When using replacement therapy, 50 percent of the total daily insulin ...
متن کاملInsulin-Dependent Diabetes Mellitus
From the School of Nursing (Drs Boehm, Schlenk, and Ronis and Ms Powers) and the Michigan Diabetes Research and Training Center, School of Medicine (Ms Funnell), University of Michigan, and the Department of Veteran’s Affairs (Dr Ronis), Ann Arbor, Michigan. Correspondence to Susan Boehm, PhD, Associate Professor and Dean, Student Affairs, The University of Michigan, School of Nursing, 400 Nort...
متن کاملOptimum Insulin Therapy in Non-insulin-dependent Diabetes Mellitus *
However, it has also been recognized that the treatment of NIDDM patients frequently is inadequate even in those patients who should achieve the target range. In a recent population based cohort the median of glycosylated haemoglobin was 10.2% in NIDDM patients treated with diet or oral hypoglycemic agents (OHA) and 11.8% in NIDDM patients who used insulin. In a 5 year follow-up study of NIDDM ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Diabetologia
سال: 1992
ISSN: 0012-186X,1432-0428
DOI: 10.1007/bf00399940